132 related articles for article (PubMed ID: 2957221)
1. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
Fletcher GH; Starr MS
Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
[TBL] [Abstract][Full Text] [Related]
2. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
3. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
Fletcher GH; Starr MS
Neuroscience; 1987 Feb; 20(2):589-97. PubMed ID: 2953990
[TBL] [Abstract][Full Text] [Related]
4. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
Arnt J
Psychopharmacology Suppl; 1985; 2():60-1. PubMed ID: 3159011
[No Abstract] [Full Text] [Related]
6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Arnt J; Hyttel J
Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
9. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
10. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats.
Criswell H; Mueller RA; Breese GR
J Neurosci; 1989 Jan; 9(1):125-33. PubMed ID: 2521511
[TBL] [Abstract][Full Text] [Related]
11. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
Starr M
J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
13. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
14. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
Robertson HA; Peterson MR; Murphy K; Robertson GS
Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
[TBL] [Abstract][Full Text] [Related]
15. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
Arnt J; Hyttel J
Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
[No Abstract] [Full Text] [Related]
16. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Breese GR; Baumeister A; Napier TC; Frye GD; Mueller RA
J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
[TBL] [Abstract][Full Text] [Related]
17. Selective inactivation of dopamine D1 and D2 receptors in 6-hydroxydopamine-lesioned rats: evidence that the effect of D1 and D2 agonists can be expressed in the absence of the heterologous DA receptor.
Arnt J; Hyttel J
Pharmacol Toxicol; 1989 Jan; 64(1):116-9. PubMed ID: 2526946
[TBL] [Abstract][Full Text] [Related]
18. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
Braun AR; Barone P; Chase TN
Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
[No Abstract] [Full Text] [Related]
19. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
Arnt J; Hyttel J
J Neural Transm; 1986; 67(3-4):225-40. PubMed ID: 2949056
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
